MedPath

STIMVIA s.r.o.

🇨🇿Czech Republic
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

24-months Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor

Not Applicable
Recruiting
Conditions
Parkinson Disease
Essential Tremor
First Posted Date
2024-08-26
Last Posted Date
2024-08-26
Lead Sponsor
Stimvia s.r.o.
Target Recruit Count
20
Registration Number
NCT06570421
Locations
🇨🇿

Cerebrovaskulární poradna s.r.o., Ostrava, Czechia

Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor

Not Applicable
Completed
Conditions
Essential Tremor
Parkinson's Disease
First Posted Date
2023-09-13
Last Posted Date
2024-08-21
Lead Sponsor
Stimvia s.r.o.
Target Recruit Count
23
Registration Number
NCT06036368
Locations
🇨🇿

Cerebrovaskulární poradna s.r.o., Ostrava, Czechia

Open Label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous URIS I in the Treatment of Overactive Bladder (OAB).

Completed
Conditions
Overactive Bladder (OAB)
Failed Any OAB Pharmacotherapy
First Posted Date
2022-01-27
Last Posted Date
2022-02-17
Lead Sponsor
Stimvia s.r.o.
Target Recruit Count
40
Registration Number
NCT05211193
Locations
🇨🇿

MUDr. Michal Rejchrt, Příbram, Czech, Czechia

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.